Advanced search
1 file | 2.36 MB

The Ghent Global IAD Monitoring Tool (GLOBIAD-M) to monitor the healing of incontinence-associated dermatitis (IAD) : design and reliability study

Karen Van den Bussche (UGent) , Sofie Verhaeghe (UGent) , Ann Van Hecke (UGent) and Dimitri Beeckman (UGent)
(2018) INTERNATIONAL WOUND JOURNAL. 15(4). p.555-564
Author
Organization
Abstract
The aim of this study was to design and evaluate the reliability of the Ghent Global incontinence-associated dermatitis (IAD) Monitoring Tool (GLOBIAD-M). The tool was designed based on the internationally validated Ghent Global IAD Categorisation Tool (GLOBIAD). After designing and validation by experts, one trained researcher carried out 36 observations of 9 patients affected with IAD. Photographs of the IAD lesions were independently assessed by a second trained researcher. Measures for inter-rater agreement (p(0)) and reliability [Cohen's Kappa (kappa) and intra-class correlation coefficients (ICC)] were analysed. The p(0) ranged between 0.86 for the item 'maceration' and 0.97 for the item 'clinical signs of infection'. The x for the item 'GLOBIAD classification' was 0.61 [95% confidence interval (CI) 0.28-0.95] and 0.72 (95% CI 0.50-0.95) for 'maceration'. The lowest x was found for the item 'oedema' (0.27; 95% CI -0.24-0.79). The ICC of the item 'redness' was 0.83 (95% CI 0.69-0.91) and 0.87 (95% CI 0.76-0.93) for 'skin loss'. The inter-rater agreement and reliability of the GLOBIAD-M appears to be good for the assessment of photographs by experts. This tool could support clinical decision-making for IAD treatment. Further validation with clinicians is, however, needed.
Keywords
assessment, incontinence-associated dermatitis, instrument, monitoring, RISK-FACTORS, SEVERITY, INSTRUMENT, AGREEMENT, ADULTS, TRIAL, SKIN

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 2.36 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Van den Bussche, Karen, Sofie Verhaeghe, Ann Van Hecke, and Dimitri Beeckman. 2018. “The Ghent Global IAD Monitoring Tool (GLOBIAD-M) to Monitor the Healing of Incontinence-associated Dermatitis (IAD) : Design and Reliability Study.” International Wound Journal 15 (4): 555–564.
APA
Van den Bussche, K., Verhaeghe, S., Van Hecke, A., & Beeckman, D. (2018). The Ghent Global IAD Monitoring Tool (GLOBIAD-M) to monitor the healing of incontinence-associated dermatitis (IAD) : design and reliability study. INTERNATIONAL WOUND JOURNAL, 15(4), 555–564.
Vancouver
1.
Van den Bussche K, Verhaeghe S, Van Hecke A, Beeckman D. The Ghent Global IAD Monitoring Tool (GLOBIAD-M) to monitor the healing of incontinence-associated dermatitis (IAD) : design and reliability study. INTERNATIONAL WOUND JOURNAL. 2018;15(4):555–64.
MLA
Van den Bussche, Karen, Sofie Verhaeghe, Ann Van Hecke, et al. “The Ghent Global IAD Monitoring Tool (GLOBIAD-M) to Monitor the Healing of Incontinence-associated Dermatitis (IAD) : Design and Reliability Study.” INTERNATIONAL WOUND JOURNAL 15.4 (2018): 555–564. Print.
@article{8562860,
  abstract     = {The aim of this study was to design and evaluate the reliability of the Ghent Global incontinence-associated dermatitis (IAD) Monitoring Tool (GLOBIAD-M). The tool was designed based on the internationally validated Ghent Global IAD Categorisation Tool (GLOBIAD). After designing and validation by experts, one trained researcher carried out 36 observations of 9 patients affected with IAD. Photographs of the IAD lesions were independently assessed by a second trained researcher. Measures for inter-rater agreement (p(0)) and reliability [Cohen's Kappa (kappa) and intra-class correlation coefficients (ICC)] were analysed. The p(0) ranged between 0.86 for the item 'maceration' and 0.97 for the item 'clinical signs of infection'. The x for the item 'GLOBIAD classification' was 0.61 [95\% confidence interval (CI) 0.28-0.95] and 0.72 (95\% CI 0.50-0.95) for 'maceration'. The lowest x was found for the item 'oedema' (0.27; 95\% CI -0.24-0.79). The ICC of the item 'redness' was 0.83 (95\% CI 0.69-0.91) and 0.87 (95\% CI 0.76-0.93) for 'skin loss'. The inter-rater agreement and reliability of the GLOBIAD-M appears to be good for the assessment of photographs by experts. This tool could support clinical decision-making for IAD treatment. Further validation with clinicians is, however, needed.},
  author       = {Van den Bussche, Karen and Verhaeghe, Sofie and Van Hecke, Ann and Beeckman, Dimitri},
  issn         = {1742-4801},
  journal      = {INTERNATIONAL WOUND JOURNAL},
  language     = {eng},
  number       = {4},
  pages        = {555--564},
  title        = {The Ghent Global IAD Monitoring Tool (GLOBIAD-M) to monitor the healing of incontinence-associated dermatitis (IAD) : design and reliability study},
  url          = {http://dx.doi.org/10.1111/iwj.12898},
  volume       = {15},
  year         = {2018},
}

Altmetric
View in Altmetric
Web of Science
Times cited: